Correlation Between Seer and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Seer and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seer and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seer Inc and Molecular Partners AG, you can compare the effects of market volatilities on Seer and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seer with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seer and Molecular Partners.
Diversification Opportunities for Seer and Molecular Partners
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Seer and Molecular is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Seer Inc and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Seer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seer Inc are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Seer i.e., Seer and Molecular Partners go up and down completely randomly.
Pair Corralation between Seer and Molecular Partners
Given the investment horizon of 90 days Seer Inc is expected to generate 0.75 times more return on investment than Molecular Partners. However, Seer Inc is 1.34 times less risky than Molecular Partners. It trades about 0.1 of its potential returns per unit of risk. Molecular Partners AG is currently generating about 0.02 per unit of risk. If you would invest 169.00 in Seer Inc on March 3, 2025 and sell it today you would earn a total of 23.00 from holding Seer Inc or generate 13.61% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Seer Inc vs. Molecular Partners AG
Performance |
Timeline |
Seer Inc |
Molecular Partners |
Seer and Molecular Partners Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Seer and Molecular Partners
The main advantage of trading using opposite Seer and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seer position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.Seer vs. Oric Pharmaceuticals | Seer vs. Anebulo Pharmaceuticals | Seer vs. Cullinan Oncology LLC | Seer vs. C4 Therapeutics |
Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges |